Reducing the over treatment of ductal carcinoma in situ (DCIS)

Please join us …

When: Thursday, November 10, 2022, 12–1 p.m.

Where: Join Zoom Meeting https://us06web.zoom.us/j/82435258546, Meeting ID: 824 3525 8546. Meeting password: 1234 OR in person in G Wing, 1st Floor (Linton Boardroom)

Who: Eileen Rakovitch, MD MSc FRCPC; Professor, Department of Radiation Oncology, University of Toronto; Cancer Program Director of Research; Sunnybrook Health Sciences Centre; Adjunct Senior Scientist, ICES; Vice-Chair Clinical Affairs, University of Toronto, Department of Radiation Oncology

Topic: Reducing the over treatment of ductal carcinoma in situ (DCIS)

Learning Objectives:

Review the challenges in reducing the overtreatment of DCIS
Review the evolving role of molecular biomarkers in the goal to reduce the overtreatment of DCIS